VGM & ASSOCIATESHealthcare MSO
Full Menu Search

VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports

Published in Government Relations on October 09, 2025

VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. 

While we recognize the importance of strengthening domestic supply chains and safeguarding national security, VGM emphasized that any resulting trade restrictions must be carefully considered to avoid unintended harm to the durable medical equipment (DME) industry and the patients it serves. 

The submitted comments outlined below include several significant challenges that the DME industry could face if the investigation leads to increased trade restrictions: 

  1. Tariffs and Cost Increases. If new tariffs are imposed on imported medical equipment and components, manufacturers will experience immediate cost hikes. Many essential parts, used in products like wheelchairs, ventilators, and hospital beds, are sourced internationally due to cost and availability. These tariffs could raise production costs, reduce affordability, and limit access for patients and providers. 
  2. Supply Chain Disruption. The DME industry depends on a global supply chain to deliver timely and diverse products. Trade restrictions or tariffs could disrupt this system, causing delays, shortages, and uncertainty, especially critical items like prosthetics, insulin pumps, and glucose monitors that are vital to patient health. 
  3. Limited Domestic Manufacturing Capacity. While boosting domestic production is a worthy goal, current U.S. infrastructure cannot quickly scale to meet demand across all DME categories. Moving away from foreign suppliers without viable domestic alternatives could lead to service gaps. Any shift must consider realistic timelines, investment needs, and workforce readiness. 
  4. Impact on Patient Care and Providers. Higher costs and reduced access to DME products will directly affect patient outcomes. Providers may have to cut services, delay treatments, or pass costs onto patients, undermining healthcare resilience and compromising care quality. 
  5. Risk of Unintended Consequences. Efforts to reduce foreign dependency must be carefully tailored. Broad, one-size-fits-all policies could unintentionally harm U.S. manufacturers who rely on global inputs, stifle innovation, and reduce competitiveness. 

VGM urges the Department of Commerce to take a balanced, collaborative approach that protects national interests without compromising patient care or destabilizing the DME industry. We encourage policymakers to engage with stakeholders across the healthcare continuum to ensure that any future policies support both supply chain resilience and the continued delivery of high-quality, affordable medical equipment to those who need it most.

To submit comments and review the full Section 232 National Security Investigation notice, go to the Federal Rulemaking Portal. 

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

Congratulations to CAMPS On This Important Legislative Victory thumbnail Congratulations to CAMPS On This Important Legislative Victory The signing of AB 1794 is another reminder of the critical role state associations play in shaping healthcare policy, removing barriers to patient care, and ensuring providers have a seat at the table when important decisions are made. Legislative successes like this do not happen by accident. They are the result of engaged members, strong advocacy efforts, and collaboration with policymakers to address real-world challenges facing providers and the patients they serve. August Recess Recap: Building Relationships, Advancing Advocacy thumbnail August Recess Recap: Building Relationships, Advancing Advocacy As Congress worked through the August recess, the VGM Government Relations team remained actively engaged in securing meetings and building relationships with legislators, candidates, and key congressional staff across the country. This summer, the team made a strategic decision to focus getting a strong balance between Republican and Democratic offices, recognizing the importance of broadening support for DMEPOS priorities and ensuring policymakers from both parties understand the challenges.. Introducing Patient Voices: Access to HME Matters thumbnail Introducing Patient Voices: Access to HME Matters The VGM Government Relations team is excited to announce Patient Voices: Access to HME Matters, a new way for patients, providers, vendors, caregivers, and industry partners to share their experiences with home medical equipment. Every story matters. AAHomecare Survey Results of RID Program thumbnail AAHomecare Survey Results of RID Program Thank you to AAHomecare for initiating this important survey demonstrating the significant risks to the DMEPOS industry should Remote Item Delivery Competitive Bid Program (RID CBP) Round 2028 move forward as is. VGM Group is proud to support the survey efforts to maximize provider participation. See below for the survey summary and analysis. Competitive Bidding Update: NPEast and NPWest Updating Licensure Requirement Information for Competitive Bidding Product Categories thumbnail Competitive Bidding Update: NPEast and NPWest Updating Licensure Requirement Information for Competitive Bidding Product Categories Per the Remote Item Delivery Competitive Bidding Program (RID CBP) Round 2028 requirements, bidders must meet all business and product category licensure requirements across every state, the District of Columbia, and the U.S. territories to be eligible to be a contract winner. New CMS Nationwide Probationary Prior Authorization Requirement for Newly Enrolled Suppliers of Certain DMEPOS Items thumbnail New CMS Nationwide Probationary Prior Authorization Requirement for Newly Enrolled Suppliers of Certain DMEPOS Items On Sept. 2, 2026, CMS introduced the Probationary Prior Authorization (PPA) program that will place newly enrolled DMEPOS Suppliers and those undergoing 100% change in ownership on a one-year probationary period. Effective Oct. 15, impacted suppliers will be required to submit a prior authorization request for specific HCPCS codes. OIG Report Signals Increased Fraud Oversight for DMEPOS Suppliers thumbnail OIG Report Signals Increased Fraud Oversight for DMEPOS Suppliers The HHS Office of Inspector General (OIG) recently released a white paper examining ongoing Medicare fraud involving durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). Preparing for Increased Audit Activity: How VGM Group and The van Halem Group Can Help thumbnail Preparing for Increased Audit Activity: How VGM Group and The van Halem Group Can Help The recent HHS Office of Inspector General (OIG) report on DMEPOS fraud signals that CMS is likely to increase oversight activities across the industry. The report calls for enhanced supplier enrollment screening, more aggressive medical reviews, expanded use of artificial intelligence and data analytics, greater physician order verification, and increased scrutiny of supplier ownership and billing practices.

Give your business an advantage over the competition.

Become a Member